The family of a cancer patient wants to stop chemotherapy in favor of a non-evidence-based 'natural' cure they found online.
This is an interactive phone call simulation. You'll speak with David in a realistic clinical communication scenario.
Click "Start Call" when you're ready. Speak naturally as you would on a real call.
10 minutes to complete the call. The AI responds in real-time to what you say.
End the call when finished. You'll receive AI-powered feedback on your communication.
💡 Tip: Speak clearly and at a natural pace. If you need a moment to think, it's okay to pause briefly - just as you would in a real conversation.
When faced with a devastating diagnosis, it is natural for patients and families to seek hope anywhere they can find it, including the world of alternative and unproven therapies. This conversation is extremely delicate. A dismissive or paternalistic approach can shatter the therapeutic alliance and push the family away from evidence-based care. The goal is to explore their hopes and fears, provide gentle education, and find common ground to continue safe, effective treatment.
Key communication strategies include:
Your objective is to have a conversation with David, the son of your patient with curable lymphoma. David has been researching online and now wants his father to stop chemotherapy and instead pursue a risky, unproven "alternative" treatment from an overseas clinic. You must navigate this conversation to keep the patient on his life-saving treatment path without alienating his son.
Your patient is a 65-year-old man with a new diagnosis of Diffuse Large B-Cell Lymphoma. His son, David, is his primary caregiver and is very involved.
Optional prep details
Optional self-check before you start
This scenario requires an account. Sign in to begin the simulation.
After completing this scenario, you will be able to:
When a patient's family expresses a desire to stop chemotherapy for an unproven online 'natural' cure, what is the most appropriate initial response to maintain the therapeutic alliance?
In the context of shared decision-making regarding unproven therapies, what is the primary goal of the clinician?